.svg){kind=small}
Apr-2026
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the first quarter of 2026, Emerald Health Therapeutics showed a notable entry into the beverage category in Ontario. After not being ranked in the top 30 for the months of January through March, they achieved a rank of 29 by April, indicating a positive movement into the competitive market. This suggests that Emerald Health Therapeutics may have introduced a new product or marketing strategy that resonated well with consumers, leading to this newfound presence in the rankings. The sales figures for April were recorded at 10,364, hinting at a promising start as they entered the top 30 list.
While the performance in Ontario shows a positive trend, the absence of Emerald Health Therapeutics in the top 30 rankings across other states and categories during the same period suggests areas where the brand could potentially expand or improve its market presence. The lack of ranking in these areas could be viewed as an opportunity for growth or a signal that the brand's current offerings may not be meeting the demands of consumers in other markets. Observing how Emerald Health Therapeutics navigates these challenges and opportunities in the coming months will be crucial for understanding its overall market strategy and adaptability.
Competitive Landscape
In the Ontario beverage category, Emerald Health Therapeutics has shown a notable entry into the competitive landscape, securing the 29th rank in April 2026. This marks its first appearance in the top 30, suggesting a positive trajectory in market presence. In contrast, CQ (Cannabis Quencher) has experienced a decline, dropping out of the top 30 by April 2026 after being ranked 24th in January. Meanwhile, Emprise Canada has emerged strongly, entering the rankings at 23rd in March 2026, indicating a robust market entry. Frootyhooty has shown fluctuations, with its rank varying between 23rd and 29th over the months, while Snap Back re-entered the rankings at 28th in April after a brief absence. These dynamics highlight a competitive and shifting landscape, with Emerald Health Therapeutics gaining ground amidst varying performances by its competitors.
Notable Products
In April 2026, the top-performing product for Emerald Health Therapeutics was the Ginger Lime Live Rosin Beverage (10mg THC, 222ml) in the Beverage category, maintaining its first-place rank for four consecutive months with sales reaching 918 units. The Lime Mint Beverage (10mg THC, 222ml) also held its steady position as the second top product, with sales increasing to 755 units in April. Notably, both products have consistently dominated their category since January 2026, showcasing strong consumer preference and stable demand. The Ginger Lime Live Rosin Beverage saw a significant sales increase from March to April, indicating a positive growth trend. Overall, Emerald Health Therapeutics' beverage offerings continue to lead the market with consistent performance and rising sales figures.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
